Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 15/20 | 0.53 |
| ▸ | CTSK | P43235 | 13/20 | 0.53 |
| ▸ | CTSL | P07711 | 14/20 | 0.52 |
| ▸ | CTSB | P07858 | 13/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6208357 | 0.92 | CTSK (0.60) | CTSSCTSKCTSLCTSB | |
| SCHEMBL4699184 | 0.88 | CTSS (0.54) | CTSSCTSKCTSLCTSB | |
| SCHEMBL4701781 | 0.88 | CTSL (0.68) | CTSSCTSKCTSLCTSB | |
| SCHEMBL4699481 | 0.86 | CTSS (0.51) | CTSSCTSKCTSLCTSB | |
| SCHEMBL4704586 | 0.82 | CTSS (0.44) | CTSSCTSKCTSLCTSB | |
| SCHEMBL6210052 | 0.82 | CTSK (0.57) | CTSSCTSKCTSLCTSB | |
| SCHEMBL4702186 | 0.81 | CTSK (0.64) | CTSSCTSKCTSLCTSB | |
| SCHEMBL6208924 | 0.81 | CTSK (0.59) | CTSSCTSKCTSLCTSB | |
| SCHEMBL4699757 | 0.81 | CTSK (0.59) | CTSSCTSKCTSLCTSB | |
| SCHEMBL4698932 | 0.80 | CTSS (0.71) | CTSSCTSKCTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1372655-A4 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | MERCK FROSST CANADA INC (CA) | 2005-10-12 | — | — | EP | claimed |
| EP-1372655-A2 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | Merck Frosst Canada & Co. (CA) | 2004-01-02 | — | — | EP | claimed |
| WO-2002069901-A2 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | MERCK FROSST CANADA & CO. (CA) | 2002-09-12 | — | — | WO | claimed |